Delpor Awarded NIH Grant for 3-month Olanzapine Implant for the...

The NIMH funds Delpor’s efforts to utilize its PROZOR™ technology in developing a matchstick-size subcutaneous implant device capable of delivering olanzapine for 3 months through passive diffusion....(PRWeb February 24, 2017)Read the full story at http://www.prweb.com/releases/2017/02/prweb14088705.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news